Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
exposure-response | relationship between drug exposure and a measured or reported effect | The clinical review compares the exposure-response relationship across the last two regimens. | Assessment | Medication exposure, response and adverse-effect reasoning |
active moiety | component responsible for pharmacologic activity in context | The report specifies which active moiety the assay measures. | Assessment | Medication exposure, response and adverse-effect reasoning |
additive risk | two or more factors may increase the same adverse outcome | The assessment notes additive risk of sedation from the combination. | Assessment | Medication exposure, response and adverse-effect reasoning |
adverse reaction | harmful unintended response attributed or suspected to be related to a drug | The timing raises concern for an adverse reaction, with causality under review. | Assessment | Medication exposure, response and adverse-effect reasoning |
anticholinergic burden | combined effects of medicines with anticholinergic activity | The review identifies high anticholinergic burden across the home medicines. | Assessment | Medication exposure, response and adverse-effect reasoning |
assay variability | variation attributable to measurement methods or performance | The small difference is being reviewed in light of assay variability. | Assessment | Medication exposure, response and adverse-effect reasoning |
bioequivalence | similarity of rate and extent of absorption under specified conditions | The dispensing review documents the reference used to verify bioequivalence. | Assessment | Medication exposure, response and adverse-effect reasoning |
biological variability | physiologic variation between measurements | Day-to-day biological variability may contribute to the observed difference. | Assessment | Medication exposure, response and adverse-effect reasoning |
clinical correlation | interpret laboratory or test data together with symptoms and examination | The isolated laboratory flag requires clinical correlation with the current findings. | Assessment | Medication exposure, response and adverse-effect reasoning |
competing explanation | another cause that could account for the same change | The intercurrent illness remains a competing explanation for the nausea. | Assessment | Medication exposure, response and adverse-effect reasoning |
| change after a suspect medicine is stopped or reduced | Nausea improved during dechallenge as documented in the medication history. | Assessment | Medication exposure, response and adverse-effect reasoning | |
delayed-release | formulation designed to delay release until later in transit or time | The history refers to the delayed-release product on the original bottle. | Assessment | Medication exposure, response and adverse-effect reasoning |
dose-response | relationship between administered dose and effect | The symptom diary suggests a dose-response pattern, although timing varies. | Assessment | Medication exposure, response and adverse-effect reasoning |
dose proportionality | whether exposure changes in proportion to the dose change | The reviewer discusses dose proportionality before comparing the two concentrations. | Assessment | Medication exposure, response and adverse-effect reasoning |
enzyme induction | increased enzyme expression or activity affecting drug handling | A new co-medication raises the possibility of enzyme induction. | Assessment | Medication exposure, response and adverse-effect reasoning |
enzyme inhibition | reduced enzyme activity affecting drug handling | The pharmacist identifies possible enzyme inhibition by a concurrent medication. | Assessment | Medication exposure, response and adverse-effect reasoning |
extended-release | formulation designed to release drug over a longer interval | The verified product is extended-release, which affects interpretation of dose timing. | Assessment | Medication exposure, response and adverse-effect reasoning |
first-pass metabolism | presystemic metabolism before drug reaches general circulation | The pharmacist discusses first-pass metabolism when comparing routes. | Assessment | Medication exposure, response and adverse-effect reasoning |
hepatotoxicity | harmful effect on the liver | The review considers drug-related hepatotoxicity alongside other causes of the enzyme rise. | Assessment | Medication exposure, response and adverse-effect reasoning |
immediate-release | formulation that releases drug without a designed delay or extension | The earlier level followed an immediate-release dose. | Assessment | Medication exposure, response and adverse-effect reasoning |
inducer | agent increasing activity or expression of a relevant pathway | The medication history includes an inducer recently discontinued. | Assessment | Medication exposure, response and adverse-effect reasoning |
inhibitor | agent reducing activity of a specified enzyme or transporter | The new prescription is listed as an inhibitor of the metabolic pathway under review. | Assessment | Medication exposure, response and adverse-effect reasoning |
interpatient variability | differences in exposure or response among individuals | The team considers interpatient variability when reviewing the population-based estimate. | Assessment | Medication exposure, response and adverse-effect reasoning |
intrapatient variability | variation within the same individual across observations | Differences in draw timing complicate estimation of intrapatient variability. | Assessment | Medication exposure, response and adverse-effect reasoning |
myelosuppression | reduction in bone marrow blood cell production | The hematologist considers treatment-related myelosuppression in the differential. | Assessment | Medication exposure, response and adverse-effect reasoning |